PULMONARY VASCULAR TOXICITY WITH TYROSINE KINASE INHIBITOR THERAPY: A RARE CASE IN A CHRONIC MYELOID LEUKEMIA PATIENTNicole Prabhu, Jeanne M. DeCara, Wendy Stock et al.|JACC CardioOncology|2022Cited by 1